AxoGen Inc
AXGN12.675USD
+0.005+0.04%
Market hours （ET）Quotes delayed by 15 min
576.87MMarket Cap
LossP/E TTM
More Details of AxoGen Inc Company
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Company Info
Ticker SymbolAXGN
Company nameAxoGen Inc
IPO dateDec 17, 1986
CEOMr. Michael Donald (Mike) Dale
Number of employees451
Security typeOrdinary Share
Fiscal year-endDec 17
Address13631 Progress Blvd.
CityALACHUA
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code32615
Phone13864626817
Websitehttps://www.axogeninc.com/
Ticker SymbolAXGN
IPO dateDec 17, 1986
CEOMr. Michael Donald (Mike) Dale
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
150.41K
-30.16%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Ms. Kathy Weiler
Ms. Kathy Weiler
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
150.41K
-30.16%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2023
FY2022
No Data
By RegionUSD
Name
Revenue
Proportion
United States
159.01M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Light Asset Management, LLC
9.82%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.55%
ArrowMark Colorado Holdings, LLC
3.49%
Morgan Stanley & Co. LLC
3.48%
Other
70.78%
Shareholders
Shareholders
Proportion
First Light Asset Management, LLC
9.82%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.55%
ArrowMark Colorado Holdings, LLC
3.49%
Morgan Stanley & Co. LLC
3.48%
Other
70.78%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
38.46%
Investment Advisor
27.64%
Hedge Fund
14.22%
Research Firm
5.24%
Individual Investor
4.80%
Pension Fund
0.48%
Bank and Trust
0.32%
Sovereign Wealth Fund
0.17%
Venture Capital
0.05%
Other
8.62%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
352
41.63M
91.41%
-2.42M
2025Q1
357
42.08M
92.45%
-1.70M
2024Q4
343
39.00M
87.97%
-5.62M
2024Q3
323
39.49M
90.05%
-1.54M
2024Q2
302
38.53M
87.94%
-4.16M
2024Q1
307
37.61M
87.02%
-4.05M
2023Q4
318
35.68M
82.81%
-5.15M
2023Q3
322
35.50M
82.64%
-5.39M
2023Q2
319
36.28M
84.47%
-3.01M
2023Q1
324
35.99M
84.11%
-3.05M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
First Light Asset Management, LLC
4.47M
9.82%
-32.58K
-0.72%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
6.87%
+93.19K
+3.07%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
5.55%
+103.94K
+4.28%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
1.59M
3.49%
-657.69K
-29.25%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.59M
3.48%
-105.62K
-6.24%
Mar 31, 2025
Soleus Capital Management, L.P.
1.45M
3.18%
-1.51M
-51.08%
Mar 31, 2025
Driehaus Capital Management, LLC
1.17M
2.57%
+217.59K
+22.80%
Mar 31, 2025
Zaderej (Karen L)
1.14M
2.51%
+71.04K
+6.62%
Mar 21, 2024
Geode Capital Management, L.L.C.
1.03M
2.25%
+19.92K
+1.98%
Mar 31, 2025
Assenagon Asset Management S.A.
1.00M
2.2%
+174.68K
+21.13%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
ROBO Global Healthcare Technology & Innovation ETF
1.87%
SPDR S&P Health Care Equipment ETF
1.2%
iShares Neuroscience and Healthcare ETF
1.14%
Fidelity Digital Health ETF
0.89%
Invesco NASDAQ Future Gen 200 ETF
0.45%
AAM Sawgrass US Small Cap Quality Growth ETF
0.44%
Fidelity Enhanced Small Cap ETF
0.13%
Vanguard US Momentum Factor ETF
0.11%
iShares Micro-Cap ETF
0.11%
Franklin US Small Cap Multifactor Index ETF
0.07%
View more
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.87%
SPDR S&P Health Care Equipment ETF
Proportion1.2%
iShares Neuroscience and Healthcare ETF
Proportion1.14%
Fidelity Digital Health ETF
Proportion0.89%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.45%
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion0.44%
Fidelity Enhanced Small Cap ETF
Proportion0.13%
Vanguard US Momentum Factor ETF
Proportion0.11%
iShares Micro-Cap ETF
Proportion0.11%
Franklin US Small Cap Multifactor Index ETF
Proportion0.07%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
